Blog

CReDO for early career cancer researcher

Photo from Pramesh CS/X

Sep 3, 2024, 13:56

CReDO for early career cancer researcher

Pramesh CS, Director at Tata Memorial Hospital, shared a post on X:

“If you are an early career cancer researcher, do apply for the CReDO, National Cancer Grid.

Convert your research idea into a full-fledged protocol ready for Ethics submission.

Opportunity to be mentored by the best cancer research faculty in the world.

CReDO is supported by NCI, NCI Center for Global Health, St. Jude Children’s Research Hospital, ASCO, World Health Organization South-East Asia, City Cancer Challenge, IAEA, MRC Clinical Trials Unit at UCL, King’s College London, The Lancet Oncology, Nature Reviews Clinical Oncology, R4HC-MENA.

Held under auspices of EORTC.

Details.

Apply online.”

Source: Pramesh CS/X

More posts by Pramesh CS on oncodaily.com

ASCO cancer City Cancer Challenge CReDO EORTC IAEA King's College London MRC Clinical Trials Unit at UCL National Cancer Grid Nature Reviews Clinical Oncology NCI NCI Center for Global Health OncoDaily Oncology Pramesh CS R4HC-MENA St. Jude Children's Research Hospital Tata Memorial Hospital The Lancet Oncology World Health Organization South-East Asia

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage